CNS/Neurology Market Research Reports & Industry Analysis
A neurologist is a medical doctor that specializes in the diagnosis, treatment and management of illnesses affecting the brain, spinal cord, and nervous system. Neurologists must complete at least three years of specialized training in neurology, after completing medical school. A neurosurgeon must go through much more extensive and rigorous schooling and training. On top of diagnosing and treating neurological disorders, neurosurgeons can also perform surgery on the brain, spinal cord, and nerves.
Pharmaceuticals in CNS/Neurology are one of leading fields in medicine in terms of funding and research. On top of growing patient numbers, there remains a comparatively high unmet need in treatment of many neurological diseases. With the potential of being one of the most lucrative therapy areas in the future pharmaceutical Industry, Alzheimer's disease offers the greatest commercial opportunity for pharmaceutical companies in neurology. Many of the therapeutic drugs used to treat CNS/Neurological disorders have lost their patent protection or market exclusivity, leading to greater research and market opportunities for competing pharmaceutical and medical device companies. Despite the widespread use of CNS drugs, knowledge of these agents is limited due to the anatomic and neurochemical complexity of the brain and spinal cord.
CNS/Neurology Industry Research & Market Reports
-
Global Neurointerventional Devices Market Size & Share to 2027
... (Neurothrombectomy, Coiling Procedure,Stenting, Cerebral Angiography), By End User, By Region and Forecast till 2027 Global Neurointerventional Devices Market Neurointerventional devices are used for neurointervention procedure which is minimally invasive treatment for disorders of the blood ... Read More
-
Meningitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Meningitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Meningitis. Report includes ... Read More
-
Clinical Trials Market Size, Share & Trends Analysis Report By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design, By Indication (Pain Management, Oncology, CNS Condition, Diabetes, Obesity), By Region, And Segment Forecasts, 2022 - 2030
... by Grand View Research, Inc. An increase in the volume and complexity of clinical trials has been witnessed lately, which plays an important role in the R&D of new drugs and products. The market witnessed ... Read More
-
Mental Wellness Market - Global Outlook & Forecast 2022-2027
... enablers, restraints, and trends in the market. The study includes the demand and supply aspects of the market. Peru data center market is expected to grow at a CAGR of 11.22% during 2022-2027 KEY HIGHLIGHTS ... Read More
-
Opium (Opioid) Addiction Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Opium (Opioid) Addiction Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Social Anxiety Disorder (SAD Social Phobia) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
... Social Phobia) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update provides an overview of Social Anxiety Disorder (SAD Social Phobia) Clinical trials scenario. ... Read More
-
Pain Management Devices Market Size, Share & Trends Analysis Report By Product (RFA, Neurostimulation), By Application (Neuropathic Pain, Cancer), By Region (APAC, North America), And Segment Forecasts, 2022 - 2030
... new report by Grand View Research, Inc. Increasing prevalence of chronic pain and technological advancements are driving the market growth. The rising prevalence of chronic diseases, coupled with the increasing geriatric population, across the globe ... Read More
-
Physiotherapy Equipment Market Size, Share & Trends Analysis Report By Application (Neurology, Musculoskeletal, Pediatrics), By Type, By Demographics, By End Use, By Region, And Segment Forecasts, 2022 - 2030
... by Grand View Research, Inc. The growing prevalence of neurological, musculoskeletal, and spinal cord disorders, early disease diagnosis, and awareness about physiotherapy are some of the factors driving the market growth. The rising incidences of ... Read More
-
Global Deep Brain Stimulation Growth Opportunities
... This will allow more patients to benefit from the therapy. According to the WHO, neurological diseases currently contribute to 6.3% of the global disease burden and are among the major causes of mortality (as high ... Read More
-
Global Synthetic Stem Cells Market Size study, by Application (Cardiovascular Disease, Neurological Disorders, Cancer, Diabetes, Gastrointestinal, Musculoskeletal Disorder), By End-Use (Hospitals And Surgical Centers, Academic Institutes, Research Laboratories, Pharmaceutical And Biotechnology Companies, Others) and Regional Forecasts 2022-2028
... Forecasts 2022-2028 Global Synthetic Stem Cells Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period ... Read More
-
Neuroimmunology Drug Development - Thematic Research
... nervous system health and disease. GlobalData defines a neuroimmunology drug as an agent that aims to regulate immune system activity to treat neurological diseases with underlying immune pathologies. Various neuroimmunology therapeutic strategies are being studied ... Read More
-
North America Digital Therapeutics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application [Diabetes, Cardiovascular Diseases, Central Nervous System (CNS) Disease, Respiratory Diseases, Smoking Cessation, Musculoskeletal Diseases, and Others] and Distribution Channel (Patients, Providers, Payers, and Employers)
... (Patients, Providers, Payers, and Employers) The North America digital therapeutics market is expected to reach US$ 7,323.29 million by 2028 from US$ 1,740.46 million in 2021; it is estimated to grow at a CAGR of ... Read More
-
South and Central America Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others)
... Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others) The South and Central America pharmacogenomics market is expected to reach US$ 591.35 million by 2028 from US$ ... Read More
-
Europe Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others)
... Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others) The Europe pharmacogenomics market is expected to reach US$ 3,874.31 million by 2028 from US$ 1,962.48 million in 2021. It is ... Read More
-
Middle East and Africa Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others)
... Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others) The Middle East and Africa pharmacogenomics market is expected to reach US$ 427.68 million by 2028 from US$ ... Read More
-
North America Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others)
... and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others) The North America pharmacogenomics market is expected to reach US$ 6,534.83 million by 2028 from US$ 3,333.43 million in 2021. ... Read More
-
Anxiety Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
... there will be more than 291 million prevalent cases of anxiety across 16 pharmaceutical markets. There are three leading marketed drugs for the treatment of anxiety, Viatris is a key player in the disease space. ... Read More
-
Brain Computer Interface Market Size, Share & Trends Analysis Report By Application (Healthcare, Communication & Control), By Product (Invasive, Non-invasive), By End Use (Medical, Military), And Segment Forecasts, 2022 - 2030
... Growth & Trends The global brain computer interface market size is expected to reach USD 6.18 billion by 2030, according to a new report by Grand View Research, Inc., registering a CAGR of 17.16% over ... Read More
-
Benzodiazepine Drugs Market, by Product (Long Acting Benzodiazepine {Chlordiazepoxide, Diazepam, Lorazepam, Alprazolam, Clonazepam, and Others}, Short Acting Benzodiazepine {Temazepam, Midazolam, Triazolam and Others), by Application (Anxiety Disorders, Nervousness, Sedation, Seizures, Alcohol Withdrawal and Others), by Route of Administration (Oral, Injectables, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Route of Administration (Oral, Injectables, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, ... Read More
-
Europe Digital Therapeutics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application [Diabetes, Cardiovascular Diseases, Central Nervous System (CNS) Disease, Respiratory Diseases, Smoking Cessation, Musculoskeletal Diseases, and Others] and Distribution Channel (Patients, Providers, Payers, and Employers)
... Providers, Payers, and Employers) The Europe digital therapeutics market is expected to reach US$ 1,338.13 million by 2028 from US$ 1,023.59 million in 2021; it is estimated to grow at a CAGR of 22.9% from ... Read More
-
Asia Pacific Digital Therapeutics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application [Diabetes, Cardiovascular Diseases, Central Nervous System (CNS) Disease, Respiratory Diseases, Smoking Cessation, Musculoskeletal Diseases, and Others] and Distribution Channel (Patients, Providers, Payers, and Employers)
... (Patients, Providers, Payers, and Employers) The Asia Pacific digital therapeutics market is expected to reach US$ 3,470.31 million by 2028 from US$ 767.23 million in 2021; it is estimated to grow at a CAGR of ... Read More
-
Asia Pacific Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others)
... and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others) The Asia Pacific pharmacogenomics market is expected to reach US$ 2,679.64 million by 2028 from US$ 1,148.36 million in 2021. ... Read More
-
North America Concussion Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type {Treatment and Diagnosis [Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, X-Rays, and Others]} and End User (Hospital & Clinics, Diagnostic Centers, and Others)
... Diagnostic Centers, and Others) The North America concussion market is expected to reach US$ 3,528.2 million by 2028 from US$ 2,719.8 million in 2021. The market is estimated to grow at a CAGR of 3.8% ... Read More
-
Middle East and Africa Concussion Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type {Treatment and Diagnosis [Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, X-Rays, and Others]} and End User (Hospital & Clinics, Diagnostic Centers, and Others)
... & Clinics, Diagnostic Centers, and Others) The Middle East & Africa concussion market is expected to reach US$ 380.0 million by 2028 from US$ 315.1 million in 2021. The market is estimated to grow at ... Read More
-
Asia Pacific Concussion Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type {Treatment and Diagnosis [Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, X-Rays, and Others]} and End User (Hospital & Clinics, Diagnostic Centers, and Others)
... Diagnostic Centers, and Others) The Asia Pacific concussion market is expected to reach US$ 2,069.1 million by 2028 from US$ 1,548.1 million in 2021. The market is estimated to grow at a CAGR of 4.2% ... Read More
Research Assistance
